Intellipharmaceutics International Inc. Quarterly Depreciation in USD from Q1 2013 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Intellipharmaceutics International Inc. quarterly/annual Depreciation history and growth rate from Q1 2013 to Q3 2023.
  • Intellipharmaceutics International Inc. Depreciation for the quarter ending August 31, 2023 was $40.6K, a 21.1% decline year-over-year.
  • Intellipharmaceutics International Inc. annual Depreciation for 2022 was $206K, a 21.2% decline from 2021.
  • Intellipharmaceutics International Inc. annual Depreciation for 2021 was $262K, a 37% decline from 2020.
  • Intellipharmaceutics International Inc. annual Depreciation for 2020 was $415K, a 18% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $40.6K -$10.9K -21.1% Jun 1, 2023 Aug 31, 2023 6-K 2023-10-16
Q2 2023 $40.5K -$10.9K -21.2% Mar 1, 2023 May 31, 2023 6-K 2023-09-26
Q4 2022 $206K $51.6K -$13.8K -21% Sep 1, 2022 Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $220K $51.5K -$13.9K -21.3% Jun 1, 2022 Aug 31, 2022 6-K 2023-10-16
Q2 2022 $234K $51.5K -$13.9K -21.3% Mar 1, 2022 May 31, 2022 6-K 2023-09-26
Q1 2022 $248K $51.5K -$13.9K -21.3% Dec 1, 2021 Feb 28, 2022 6-K 2022-04-14
Q4 2021 $262K $65.4K -$42.6K -39.5% Sep 1, 2021 Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $304K $65.4K -$36.9K -36.1% Jun 1, 2021 Aug 31, 2021 6-K 2022-10-14
Q2 2021 $341K $65.4K -$37K -36.2% Mar 1, 2021 May 31, 2021 6-K 2022-07-21
Q1 2021 $378K $65.4K -$37.3K -36.3% Dec 1, 2020 Feb 28, 2021 6-K 2022-04-14
Q4 2020 $415K $108K -$20.6K -16% Sep 1, 2020 Nov 30, 2020 20-F/A 2024-02-06
Q3 2020 $436K $102K -$23.7K -18.8% Jun 1, 2020 Aug 31, 2020 6-K 2021-10-15
Q2 2020 $460K $102K -$23.5K -18.6% Mar 1, 2020 May 31, 2020 6-K 2021-07-15
Q1 2020 $483K $103K -$23.5K -18.6% Dec 1, 2019 Feb 29, 2020 6-K 2021-04-14
Q4 2019 $507K $129K -$26.8K -17.2% Sep 1, 2019 Nov 30, 2019 20-F/A 2022-05-09
Q3 2019 $533K $126K -$29.3K -18.9% Jun 1, 2019 Aug 31, 2019 6-K 2020-10-15
Q2 2019 $563K $126K -$27.9K -18.2% Mar 1, 2019 May 31, 2019 6-K 2020-07-15
Q1 2019 $591K $126K -$22K -14.9% Dec 1, 2018 Feb 28, 2019 6-K 2020-05-29
Q4 2018 $613K $155K Sep 1, 2018 Nov 30, 2018 20-F 2021-03-31
Q3 2018 $155K +$16.9K +12.2% Jun 1, 2018 Aug 31, 2018 6-K 2019-10-11
Q2 2018 $154K +$40.6K +35.8% Mar 1, 2018 May 31, 2018 6-K 2019-07-10
Q1 2018 $148K Dec 1, 2017 Feb 28, 2018 6-K 2019-04-15
Q3 2017 $138K Jun 1, 2017 Aug 31, 2017 6-K 2018-10-15
Q2 2017 $113K Mar 1, 2017 May 31, 2017 6-K/A 2018-07-24
Q1 2014 $71.6K -$21.5K -23.1% Dec 1, 2013 Feb 28, 2014 6-K 2014-04-14
Q1 2013 $93.1K Dec 1, 2012 Feb 28, 2013 6-K 2014-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.